Rxcell Announces $4,600,000 Investment From Dmr Global Venture And Regenosis, Plans For Second Raise Of $15,000,000 For Ind Testing In Q4 2023
Amount Raised
$4.6 Million
Round Type
Seed
SingaporeBiotechnologyHealth CareTherapeuticsInvestors
Description
RxCell, a pioneering biotech company focusing on cellular therapeutics for age-related diseases, today proudly announces a $4,600,000 investment commitment from DMR Global Venture LLC and Regenosis. Building on the strength of collaboration with National University of Singapore, this fresh investment accentuates RxCell’s resolute drive to revolutionize age-related disease treatment.
Quick answer
RxCell raised $4.6 Million in a Seed round, dated December 5, 2023. Investors: National University Of Singapore (Nus), Regenosis and DMR Global Venture LLC. RxCell is based in Singapore.
- How much did RxCell raise?
- RxCell raised $4.6 Million in a Seed round on December 5, 2023.
- Who invested in RxCell?
- National University Of Singapore (Nus), Regenosis and DMR Global Venture LLC are named as investors in this round.
- What does RxCell do?
- RxCell Inc. is a forerunner in the cell therapy domain, particularly in the therapeutic applications of induced pluripotent stem cells (iPSCs).
- Where is RxCell based and how big is it?
- RxCell is based in Singapore.
- Who are the decision-makers at RxCell?
- Fundz holds 1 contact at RxCell. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as RxCell that raised within 45 days of this round, from Fundz verified event records.
- Calidi Biotherapeutics raised $10K on January 19, 2024.
- Ratio Therapeutics raised $50M (Series B) on January 17, 2024.
- Gallant raised $15M (Series A) on January 8, 2024.
- Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
- OnCusp Therapeutics raised $100M (Series A) on January 4, 2024.
- Liquidia raised $100M (Funding Round) on January 4, 2024.
Who to call at RxCell, and when
A new round usually means RxCell is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RxCell raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RxCell, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RxCell. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RxCell raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
RxCell raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.